ORX:STO
Orexo AB
0,88 SEK
arrow_upward
+1,27%(+0,011) 1D
13-ноя., 17:29:57 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
0,90 SEK
High
0,90 SEK
Low
0,83 SEK
Mkt. cap
308,06 млн
Avg. vol.
739,90 миң
Volume
0,00
P/E ratio
0,06
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
0,90 SEK
High
0,90 SEK
Low
0,83 SEK
Mkt. cap
308,06 млн
Avg. vol.
739,90 миң
Volume
0,00
P/E ratio
0,06
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
The Motley Fool
·
30 мүнөт мурун
The S&P 500 Looks Cheaper Than It Has in Over 3 Years, but There’s a Catch
Benzinga
·
1 саат мурун
Stock Market: Will S&P 500 Open Up or Down Today?
BigGo Finance
·
18 саат мурун
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
StoneX
·
2 күн мурун
S&P 500, Nasdaq 100 Claw Back But NVDA Cloud Looms Overhead
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com